NeuroDerm Ltd.
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Subsidiary
- Established
- 2003-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.neuroderm.com
Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- NeuroDerm Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01486628
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center, Jerusalem, Israel
A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
- First Posted Date
- 2010-10-27
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- NeuroDerm Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01229332
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center, Jerusalem, Israel
A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
- First Posted Date
- 2010-08-03
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- NeuroDerm Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01174355
- Locations
- ๐ฎ๐ฑ
Shalvata Mental Health Center (SMHC), Hod Hasharon, Israel
๐ฎ๐ฑRambam Hospital, Haifa, Israel
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2010-10-05
- Lead Sponsor
- NeuroDerm Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT01103011
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center, Jerusalem, Israel
ยฉ Copyright 2024. All Rights Reserved by MedPath